The association between sPD-1 levels versus liver biochemistry and viral markers in chronic hepatitis B patients: a comparative study of different sPD-1 assays

Virology Journal

Wen-Juei Jeng¹  Chien-Hung Chen¹  Chia-Wei Lin¹  Chun-Yen Lin¹  Mei-Hung Pan²  Yi-Wen Wang²  Hwai-I Yang² 

[1] Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital;Genomics Research Center, Academia Sinica;

关键词: Immune markers;    PD-1;    Assay;    Hepatitis B virus;   

DOI  :  10.1186/s12985-022-01777-3

来源: DOAJ

【 摘 要 】

Abstract Background Soluble programmed death-1 (sPD-1) is a novel immune markers and possibly predictive of chronic hepatitis B (CHB) outcome. However, results were inconsistent by different ELISA kits. This study aims to compare the characteristics and correlations with other markers for sPD-1 measured by MyBioSource (MB) and R&D (RD) kits. Methods A total of 254 untreated CHB patients from three sites were assayed with sPD-1 by MB and RD kits at the same time. Spearman’s correlations between the kits, and those with viral markers and ALT levels were calculated. Multivariate linear regression analysis was applied for independent factors associated with the sPD-1 levels. Results There’s no correlation between sPD-1 level using MB and RD assays. sPD-1 by MB correlated profoundly with HBsAg (r = 0.8311, P < 0.0001), HBV DNA (r = 0.3896, P < 0.0001), and ALT levels (r = 0.1604, P = 0.0105) while an opposite trend by RD kit (r = − 0.0644, P = 0.3109; r = 0.2554, P < 0.0001; r = 0.4417, P < 0.0001, respectively for the 3 markers). In the multivariate linear regression analysis, HBsAg and ALT levels was the major factor associated with sPD-1 levels by MB and RD, respectively. Conclusions The characteristics and correlations with host/viral markers of sPD-1 by the two kits are different and leading to different associations on clinical outcomes of CHB.

【 授权许可】

Unknown